Search Results 2521-2530 of 17343 for Green Birth Control

  1. Cesarean Delivery Multicenter Intraoperative Discomfort - Mayo Clinic

    The investigation seeks to control and cover pain management and enhance postoperative patient follow up. Participation eligibility. Participant eligibility ...

  2. Study of Onvansertib in Combination With FOLFIRI and Bevacizumab Versus FOLFIRI and Bevacizumab for Second Line Treatment of Metastatic Colorectal Cancer in Participants With a Kirsten Rat Sarcoma Virus Gene (KRAS) or Neuroblastoma-RAS (NRAS) Mutation - Mayo Clinic

    Study of Onvansertib in Combination With FOLFIRI and Bevacizumab Versus FOLFIRI and Bevacizumab for Second Line Treatment of Metastatic Colorectal Cancer in ...

  3. Study of AZD0466 Monotherapy or in Combination in Patients With Advanced Haematological Malignancies - Mayo Clinic

    control is permitted but must be discontinued at least 2 days prior to the first dose of study treatment. Treatment with hydroxyurea is permitted ...

  4. Penile Length Restoration in Men with Type II Diabetes - Mayo Clinic

    The purpose of this study is to assess penile length pre- and post-completion of RestoreX® traction therapy compared to control groups (no treatment) among men ...

  5. Featured News - 2019 Archives

    A list of seven surfaces that harbor a staggering number of germs is a great reminder to protect yourself by taking one important step over[...].

  6. Quality of Lifeof Children and Youth With Spina Bifida and Their Caregivers - Mayo Clinic

    ... population. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns ...

  7. A Study of the Safety, Tolerability, and Drug/Body Interactions of C2N-8E12 in People with Progressive Supranuclear Palsy - Mayo Clinic

    ... controlled phase 2/3 trial. Boxer AL. Adam L; Lang AE. Anthony E; Grossman M. Murray; Knopman DS. David S; Miller BL. Bruce L; Schneider LS. Lon S; Doody RS ...

  8. Epicardial Delivery Of XC001 Gene Therapy To Promote Angiogenesis In CAD Patients Undergoing Treatment With CABG - Mayo Clinic

    About this study. This is a 26-week (with a 26-week extension) multicenter, randomized, double-blind, placebo-controlled Phase 2 study of XC001 versus ...

  9. Blood Pressure Measurement in an Outpatient Clinic Setting

    Adult population (> 18 years of age) following routine clinic appointments at Mayo Clinic Health System Eastridge clinic and New Prague clinic. Exclusion ...

  10. Role of the Gut Microbiome in Pulmonary Hypertension - Mayo Clinic

    Inclusion Criteria - for Control Subjects: Age ≥ 18 years old. Individual is competent and willing to provide consent. No diagnosis of PH or other lung ...